Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for VTXPF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for VTXPF and 80,000+ other tickers.
See exactly how VTXPF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for VTXPF and 80,000+ other tickers.
Victrex plc operates globally, focusing on the development, manufacturing, and distribution of high-performance polymers through its various subsidiaries. The company structures its comprehensive operations across two primary segments: Industrial and Medical. A core focus involves pioneering PEEK and PAEK polymer solutions, which it supplies as both semi-finished products and fully engineered parts. Furthermore, Victrex delivers specialized material solutions specifically tailored for medical device manufacturers, offers a range of thermoplastic polymer components, and undertakes various…
Victrex PLC (LSE:VCT) has spent much of the past seven years falling short of the standards it set during its heyday, but Stifel believes the specialist polymer maker is approaching an inflection point under new chief executive Jakob Sigurd Routh. The broker initiated coverage with a 'buy' rating and a 750p price target, arguing that with the FTSE 250 group's earnings at the lowest level since 2009, risk is "asymmetrically upside weighted" and the shares offer "an attractive entry point".
Victrex plc (VTXPY) Q2 2026 Earnings Call Transcript
Victrex PLC (OTCMKTS:VTXPF - Get Free Report) was the target of a large decline in short interest in January. As of January 15th, there was short interest totaling 27,014 shares, a decline of 81.6% from the December 31st total of 146,934 shares. Approximately 0.0% of the company's shares are short sold. Based on an average
Victrex plc (VTXPF) Q4 2025 Earnings Call Transcript
Victrex plc (OTCPK:VTXPF) Q3 2025 Sales/ Trading Statement Call July 8, 2025 3:30 AM ET Company Participants Ian Clifford Melling - CFO & Executive Director Jakob O. Sigurdsson - CEO & Executive Director Vivienne Cox - Corporate Participant Conference Call Participants Christian Bell - UBS Investment Bank, Research Division Jens Harry Lindqvist - Investec Bank plc, Research Division Kevin Christopher Fogarty - Deutsche Bank AG, Research Division Matthew John Peter Yates - BofA Securities, Research Division Melwin Mehta - Unidentified Company Vanessa Jeffriess - Jefferies LLC, Research Division Operator Good day, ladies and gentlemen, and welcome to the Victrex Q3 interim management statement.